RxDoctor Payments DataLook up a doctor →

Ilyas Colombowala, MD

Clinical Cardiac Electrophysiology · Houston, TXNPI 1730194150

Payments from drug & device makers

$361,866in general payments, 2019–2025

Across 741 payments — averaging $488.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cvrx, Inc.$129K
  • Medtronic$127K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$47K
  • Livanova USA, Inc.$29K
  • E.r. Squibb & Sons, L.L.C.$14K
  • Abbott$5K
  • plus $10K from 22 others
$200in research payments, 2019–2025

Across 1 payment — averaging $200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$200

What the payments were for

  • Consulting fees$24,32512%
  • Speaking & faculty fees$137,45067%
  • Travel & lodging$23,63312%
  • Food & beverage$18,2279%
  • Education$2310%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$361,866 in reported general payments places this provider in the 85th percentile of 233 clinical cardiac electrophysiology providers in Texas.

See all clinical cardiac electrophysiology providers in Texas

Medicare billing

Part B allowed, 2024
$67,748
Medicare patients
95
Services billed
374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium14$165

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →